<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33277290</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>04</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Multicentre, prospective registry study of amyotrophic lateral sclerosis in mainland China (CHALSR): study protocol.</ArticleTitle><Pagination><StartPage>e042603</StartPage><MedlinePgn>e042603</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e042603</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-042603</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Amyotrophic lateral sclerosis (ALS) is a representative rare disease characterised by progressive, fatal motor neuron degeneration. Due to the unknown aetiology and variability of the phenotypes, there are no accurate reports concerning the epidemiology or clinical characteristics of the disease. The low prevalence, as previously reported, makes it difficult to carry out studies with large samples. The aim of this study was to explore the natural history and clinical features of ALS in mainland China through a multicentre, prospective cohort study. The findings will both offer a better understanding of ALS and also support the development of a model to study other rare diseases.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">Patients from 88 representative hospitals in different parts of mainland China will be recruited through a specially designed online data system (http://www.chalsr.net/). We aim to recruit 4752 ALS patients over a 3-year period. Baseline data will be recorded, and follow-up data will be collected every 3 months. The primary outcome is effective survival. Overall survival and indices of disease progression will be measured as the secondary outcomes.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Ethical approval has been obtained from the ethics committee of Peking University Third Hospital (M2019388). Informed written consent will be obtained from each participant. Dissemination of the study protocol and data will take place primarily through a specially designed online data system (http://www.chalsr.net/). The collective results of the study will be published in peer-reviewed journals and shared in scientific presentations.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT04328675.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Jia Yu</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurology, Beijing Hospital, Beijing, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Jingxia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Zhangyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Neurology, Fujian Medical University Union Hospital, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Sha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6679-0864</Identifier><AffiliationInfo><Affiliation>Neurology, Peking University Third Hospital, Beijing, China dsfan2010@sohu.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04328675</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adult neurology</Keyword><Keyword MajorTopicYN="N">motor neurone disease</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>5</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33277290</ArticleId><ArticleId IdType="pmc">PMC7722390</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2020-042603</ArticleId><ArticleId IdType="pii">bmjopen-2020-042603</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsai M-J, Hsu C-Y, Sheu C-C. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:1602. 10.1056/NEJMc1710379</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1710379</ArticleId><ArticleId IdType="pubmed">29048142</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. . Amyotrophic lateral sclerosis. Lancet 2017;390:2084&#x2013;98. 10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A, Young CA, Hughes DA. Economic studies in motor neurone disease: a systematic methodological review. Pharmacoeconomics 2017;35:397&#x2013;413. 10.1007/s40273-016-0478-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-016-0478-9</ArticleId><ArticleId IdType="pubmed">27975196</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2016 Motor Neuron Disease Collaborators Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2018;17:1083&#x2013;97. 10.1016/S1474-4422(18)30404-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30404-6</ArticleId><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, et al. . Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol 2020;267:944&#x2013;53. 10.1007/s00415-019-09652-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, et al. . Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81:385&#x2013;90. 10.1136/jnnp.2009.183525</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ovidio F, Rooney JPK, Visser AE, et al. . Critical issues in ALS case-control studies: the case of the Euro-MOTOR study. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:411&#x2013;8. 10.1080/21678421.2017.1285939</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1285939</ArticleId><ArticleId IdType="pubmed">28594593</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Millul A, Micheli A, et al. . Incidence of ALS in Lombardy, Italy. Neurology 2007;68:141&#x2013;5. 10.1212/01.wnl.0000250339.14392.bb</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000250339.14392.bb</ArticleId><ArticleId IdType="pubmed">17210896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Vajda A, Heverin M, et al. . Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology 2015;84:1537&#x2013;44. 10.1212/WNL.0000000000001477</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001477</ArticleId><ArticleId IdType="pubmed">25770197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Brayne C, et al. . The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry 2017;88:557&#x2013;63. 10.1136/jnnp-2016-314495</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314495</ArticleId><ArticleId IdType="pubmed">28285264</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Chen L, Wang S, et al. . Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study. J Neurol Neurosurg Psychiatry 2020;91:520&#x2013;5. 10.1136/jnnp-2019-322317</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322317</ArticleId><ArticleId IdType="pubmed">32139654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, et al. . Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry 2015;86:1075&#x2013;81. 10.1136/jnnp-2015-310471</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310471</ArticleId><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Logroscino G, Boum&#xe9;diene F, et al. . Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol 2016;31:229&#x2013;45. 10.1007/s10654-015-0090-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0090-x</ArticleId><ArticleId IdType="pubmed">26458931</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaldivar T, Gutierrez J, Lara G, et al. . Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009;72:1640&#x2013;5. 10.1212/WNL.0b013e3181a55f7b</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a55f7b</ArticleId><ArticleId IdType="pubmed">19433736</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts AL, Johnson NJ, Chen JT, et al. . Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology 2016;87:2300&#x2013;8. 10.1212/WNL.0000000000003298</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003298</ArticleId><ArticleId IdType="pmc">PMC5135021</ArticleId><ArticleId IdType="pubmed">27742817</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, Debray TPA, Visser AE, et al. . Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 2018;17:423&#x2013;33. 10.1016/S1474-4422(18)30089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Unal H, Rosenbohm A, et al. . Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia. BMC Neurol 2013;13:22. 10.1186/1471-2377-13-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-22</ArticleId><ArticleId IdType="pmc">PMC3582473</ArticleId><ArticleId IdType="pubmed">23414001</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond J, Oskarsson B, Mehta P, et al. . Clinical characteristics of a large cohort of US participants enrolled in the National amyotrophic lateral sclerosis (ALS) registry, 2010-2015. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:413&#x2013;20. 10.1080/21678421.2019.1612435</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1612435</ArticleId><ArticleId IdType="pmc">PMC6946020</ArticleId><ArticleId IdType="pubmed">31131638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zive DM, Cook J, Yang C, et al. . Implementation of a novel electronic health Record-Embedded physician orders for life-sustaining treatment system. J Med Syst 2016;40:245. 10.1007/s10916-016-0605-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-016-0605-3</ArticleId><ArticleId IdType="pubmed">27696173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Zhou X, Han J. China launched a pilot project to improve its rare disease healthcare levels. Orphanet J Rare Dis 2014;9:14. 10.1186/1750-1172-9-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-9-14</ArticleId><ArticleId IdType="pmc">PMC3937133</ArticleId><ArticleId IdType="pubmed">24468030</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Liu S, Zhu C, et al. . National rare diseases registry system of China and related cohort studies: vision and roadmap. Hum Gene Ther 2018;29:128&#x2013;35. 10.1089/hum.2017.215</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2017.215</ArticleId><ArticleId IdType="pubmed">29284292</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Chen L, Rosenbohm A, et al. . Prognostic factors in ALS: a comparison between Germany and China. J Neurol 2019;266:1516&#x2013;25. 10.1007/s00415-019-09290-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09290-4</ArticleId><ArticleId IdType="pubmed">30923935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et al. . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265&#x2013;7. 10.1212/01.wnl.0000194316.91908.8a</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, et al. . Als genetics, mechanisms, and therapeutics: where are we now? Front Neurosci 2019;13:1310. 10.3389/fnins.2019.01310</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology 2009;73:1693&#x2013;8. 10.1212/WNL.0b013e3181c1df48</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1df48</ArticleId><ArticleId IdType="pmc">PMC2788806</ArticleId><ArticleId IdType="pubmed">19917993</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Su F-C, Callaghan BC, et al. . Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLoS One 2014;9:e101186. 10.1371/journal.pone.0101186</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0101186</ArticleId><ArticleId IdType="pmc">PMC4076303</ArticleId><ArticleId IdType="pubmed">24979055</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek AM, Barchowsky A, Bowser R, et al. . Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res 2012;117:112&#x2013;9. 10.1016/j.envres.2012.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2012.06.007</ArticleId><ArticleId IdType="pubmed">22819005</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature 2016;539:197&#x2013;206. 10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, et al. . Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008;79:6&#x2013;11. 10.1136/jnnp.2006.104828</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.104828</ArticleId><ArticleId IdType="pubmed">18079297</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, Visser AE, D'Ovidio F, et al. . Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. J Neurol Neurosurg Psychiatry 2020;91:33&#x2013;9. 10.1136/jnnp-2019-320986</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320986</ArticleId><ArticleId IdType="pubmed">31434759</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, Visser AE, D'Ovidio F, et al. . Associations of electric shock and extremely low-frequency magnetic field exposure with the risk of amyotrophic lateral sclerosis. Am J Epidemiol 2019;188:796&#x2013;805. 10.1093/aje/kwy287</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwy287</ArticleId><ArticleId IdType="pubmed">30649156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney JPK, Visser AE, D'Ovidio F, et al. . A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR. Neurology 2017;89:1283&#x2013;90. 10.1212/WNL.0000000000004390</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004390</ArticleId><ArticleId IdType="pubmed">28835399</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ovidio F, Rooney JPK, Visser AE, et al. . Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study. J Neurol Neurosurg Psychiatry 2019;90:11&#x2013;19. 10.1136/jnnp-2018-318559</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318559</ArticleId><ArticleId IdType="pubmed">30076269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>